News | February 04, 2026
Wanbury achieves first sales invoicing and commercial shipment milestone
This achievement validates global demand and catapults Wanbury into high-growth acceleration
This achievement validates global demand and catapults Wanbury into high-growth acceleration
The Union Budget makes a clear and timely choice by placing biopharma at the centre of India’s next manufacturing wave
rofitability showed strong momentum, with EBITDA rising 44.9% YoY to Rs. 8,697 million
A PhD in Pharmaceutical Sciences, Dr Singh has led global regulatory audits, product validations, and quality systems spanning therapeutic formulations, dietary supplements, and functional foods
Plant 1 continues to serve as a core manufacturing hub for oral solid dosage forms
Galenicum will oversee development, manufacturing and supply, while Lupin will handle regulatory submissions, approvals, and commercialization and distribution of Semaglutide across 23 countries globally
The company recorded revenue of Rs. 1,065 crore in the third quarter of FY26
The updated closure system introduces intuitive handling, innovative functionality and a premium design compatible with a wide range of syringe formats
The BD Neopak Glass Prefillable Syringe platform is designed for the complex needs of biologics and combination products
Our scientists found that toxicological data for most PFAS are incomplete or unavailable, leaving significant uncertainty about consumer safety
Subscribe To Our Newsletter & Stay Updated
